233 related articles for article (PubMed ID: 30101499)
1. Endoscopic findings corresponding to multiple Lugol-voiding lesions in the esophageal background mucosa.
Matsuno K; Ishihara R; Nakagawa K; Ohmori M; Iwagami H; Inoue S; Iwatsubo T; Nakahira H; Matsuura N; Shichijyo S; Maekawa A; Takashi K; Yamamoto S; Takeuchi Y; Higashino K; Uedo N; Matsunaga T
J Gastroenterol Hepatol; 2019 Feb; 34(2):390-396. PubMed ID: 30101499
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristic of esophageal cancer without lugol-voiding lesions in the background esophagus.
Kuwabara H; Chiba H; Tachikawa J; Okada N; Ashikari K; Arimoto J; Nakaoka M; Sakai E; Goto T; Ohata K
Dig Endosc; 2020 May; 32(4):621-627. PubMed ID: 31965622
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of esophageal squamous cell carcinomas and lugol-voiding lesions in patients with head and neck squamous cell carcinoma.
Fukuhara T; Hiyama T; Tanaka S; Oka S; Yoshihara M; Arihiro K; Chayama K
J Clin Gastroenterol; 2010 Feb; 44(2):e27-33. PubMed ID: 19730116
[TBL] [Abstract][Full Text] [Related]
4. Association of multiple Lugol-voiding lesions with synchronous and metachronous esophageal squamous cell carcinoma in patients with head and neck cancer.
Muto M; Hironaka S; Nakane M; Boku N; Ohtsu A; Yoshida S
Gastrointest Endosc; 2002 Oct; 56(4):517-21. PubMed ID: 12297767
[TBL] [Abstract][Full Text] [Related]
5. Factors associated with the presence of multiple Lugol-voiding lesions in patients with esophageal squamous-cell carcinoma.
Katada C; Muto M; Tanabe S; Higuchi K; Sasaki T; Azuma M; Ishido K; Katada N; Sakuramoto S; Yamashita K; Masaki T; Nakayama M; Okamoto M; Koizumi W
Dis Esophagus; 2014 Jul; 27(5):457-62. PubMed ID: 23009284
[TBL] [Abstract][Full Text] [Related]
6. Blue laser imaging identifies endoscopic findings corresponding to metachronous esophageal squamous cell carcinoma.
Azuma Y; Dohi O; Naito Y; Yasuda T; Yoshida T; Ishida T; Kitae H; Matsumura S; Doi T; Hirose R; Inoue K; Yoshida N; Kamada K; Uchiyama K; Takagi T; Ishikawa T; Konishi H; Nishimura A; Kishimoto M; Itoh Y
Esophagus; 2022 Apr; 19(2):278-286. PubMed ID: 34773554
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological features of narrow-band imaging endoscopy and immunohistochemistry in ultraminute esophageal squamous neoplasms.
Goda K; Dobashi A; Yoshimura N; Chiba M; Fukuda A; Nakao Y; Ohya TR; Sasaki Y; Kato M; Aihara H; Sumiyama K; Toyoizumi H; Kato T; Tajiri H; Ikegami M
Dis Esophagus; 2014 Apr; 27(3):267-75. PubMed ID: 23796261
[TBL] [Abstract][Full Text] [Related]
8. Metachronous multiple esophageal squamous cell carcinomas and Lugol-voiding lesions after endoscopic mucosal resection.
Urabe Y; Hiyama T; Tanaka S; Oka S; Yoshihara M; Arihiro K; Chayama K
Endoscopy; 2009 Apr; 41(4):304-9. PubMed ID: 19340732
[TBL] [Abstract][Full Text] [Related]
9. Lugol-voiding lesions are an important risk factor for a second primary squamous cell carcinoma in patients with esosphageal cancer or head and neck cancer.
Hori K; Okada H; Kawahara Y; Takenaka R; Shimizu S; Ohno Y; Onoda T; Sirakawa Y; Naomoto Y; Yamamoto K
Am J Gastroenterol; 2011 May; 106(5):858-66. PubMed ID: 21468010
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive mutational analysis of background mucosa in patients with Lugol-voiding lesions.
Akizue N; Okimoto K; Arai M; Hirotsu Y; Amemiya K; Oura H; Kaneko T; Tokunaga M; Ishikawa K; Ohta Y; Taida T; Saito K; Maruoka D; Matsumura T; Nakagawa T; Nishimura M; Chiba T; Matsushita K; Mochizuki H; Yokosuka O; Omata M; Kato N
Cancer Med; 2021 Jun; 10(11):3545-3555. PubMed ID: 33934524
[TBL] [Abstract][Full Text] [Related]
11. Narrow band imaging versus lugol chromoendoscopy to diagnose squamous cell carcinoma of the esophagus: a systematic review and meta-analysis.
Morita FH; Bernardo WM; Ide E; Rocha RS; Aquino JC; Minata MK; Yamazaki K; Marques SB; Sakai P; de Moura EG
BMC Cancer; 2017 Jan; 17(1):54. PubMed ID: 28086818
[TBL] [Abstract][Full Text] [Related]
12. Artificial intelligence diagnostic system predicts multiple Lugol-voiding lesions in the esophagus and patients at high risk for esophageal squamous cell carcinoma.
Ikenoyama Y; Yoshio T; Tokura J; Naito S; Namikawa K; Tokai Y; Yoshimizu S; Horiuchi Y; Ishiyama A; Hirasawa T; Tsuchida T; Katayama N; Tada T; Fujisaki J
Endoscopy; 2021 Nov; 53(11):1105-1113. PubMed ID: 33540446
[TBL] [Abstract][Full Text] [Related]
13. Evaluating synchronous esophageal cancer in head and neck cancer patients using Lugol dye chromoendoscopy.
Laohawiriyakamol S; Sunpaweravong S; Leelamanit V; Pruegsanusak K; Sinkijcharoenchai W
J Med Assoc Thai; 2014 Nov; 97(11):1164-70. PubMed ID: 25675681
[TBL] [Abstract][Full Text] [Related]
14. Delineating the extent of esophageal squamous cell carcinoma.
Kono M; Kanesaka T; Ishihara R; Kitamura M; Shoji A; Inoue T; Matsueda K; Miyake M; Waki K; Shimamoto Y; Fukuda H; Iwagami H; Matsuura N; Nakahira H; Shichijo S; Maekawa A; Yamamoto S; Takeuchi Y; Higashino K; Uedo N; Michida T; Nakatsuka SI; Fujiwara Y
Esophagus; 2021 Oct; 18(4):790-796. PubMed ID: 34052934
[TBL] [Abstract][Full Text] [Related]
15. Narrow-band imaging versus Lugol chromoendoscopy for esophageal squamous cell cancer screening in normal endoscopic practice: randomized controlled trial.
Gruner M; Denis A; Masliah C; Amil M; Metivier-Cesbron E; Luet D; Kaasis M; Coron E; Le Rhun M; Lecleire S; Antonietti M; Legoux JL; Lefrou L; Renkes P; Tarreirias AL; Balian P; Rey P; Prost B; Cellier C; Rahmi G; Samaha E; Fratte S; Guerrier B; Landel V; Touzet S; Ponchon T; Pioche M
Endoscopy; 2021 Jul; 53(7):674-682. PubMed ID: 32698233
[TBL] [Abstract][Full Text] [Related]
16. Risk of superficial squamous cell carcinoma developing in the head and neck region in patients with esophageal squamous cell carcinoma.
Katada C; Muto M; Nakayama M; Tanabe S; Higuchi K; Sasaki T; Azuma M; Ishido K; Katada N; Yamashita K; Nemoto M; Shibata T; Masaki T; Okamoto M; Koizumi W
Laryngoscope; 2012 Jun; 122(6):1291-6. PubMed ID: 22674532
[TBL] [Abstract][Full Text] [Related]
17. Multiple foci of dilated vessels as a new predictor of metachronous esophageal cancer.
Kawakami Y; Ishihara R; Matsuno K; Waki K; Shichijo S; Yoshii S; Kanesaka T; Yamamoto S; Takeuchi Y; Higashino K; Uedo N; Michida T; Tanaka Y
Dig Endosc; 2024 Apr; 36(4):421-427. PubMed ID: 37553826
[TBL] [Abstract][Full Text] [Related]
18. Narrow-band imaging vs Lugol chromoendoscopy in screening for esophageal squamous cell neoplasia: a randomized trial.
Chaber-Ciopinska A; Kiprian D; Wieszczy P; Bielasik A; Bugajski M; Januszewicz W; Jarzabski A; Niemiec M; Mroz A; Kawecki A; Regula J; Kaminski MF
Pol Arch Intern Med; 2023 Oct; 133(10):. PubMed ID: 36916462
[TBL] [Abstract][Full Text] [Related]
19. Lugol chromo-endoscopy versus narrow band imaging for endoscopic screening of esophageal squamous-cell carcinoma in patients with a history of cured esophageal cancer: a feasibility study.
Lecleire S; Antonietti M; Iwanicki-Caron I; Duclos A; Lemoine F; Pessot FL; Michel P; Ducrotté P; Di Fiore F
Dis Esophagus; 2011 Aug; 24(6):418-22. PubMed ID: 21309914
[TBL] [Abstract][Full Text] [Related]
20. Alcohol Consumption and Multiple Dysplastic Lesions Increase Risk of Squamous Cell Carcinoma in the Esophagus, Head, and Neck.
Katada C; Yokoyama T; Yano T; Kaneko K; Oda I; Shimizu Y; Doyama H; Koike T; Takizawa K; Hirao M; Okada H; Yoshii T; Konishi K; Yamanouchi T; Tsuda T; Omori T; Kobayashi N; Shimoda T; Ochiai A; Amanuma Y; Ohashi S; Matsuda T; Ishikawa H; Yokoyama A; Muto M
Gastroenterology; 2016 Nov; 151(5):860-869.e7. PubMed ID: 27492616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
